|
|
|
|
The efficacy and safety of metrifonate,an acetylcholinesterase inhibitor, was evaluated clinically in patients diagnosed with mild to moderate Alzheimer's disease(AD).The drug was well-tolerated;side effects were predominantly gastrointestinal in nature,and no hepatic toxicity was noted.Therefore,in this study,metrifonate safely improved the cognitive deficits and benefited the global function of AD patients. |
|